2seventy bio
company
Funding Round
Post-IPO Equity
Money Raised
$ 20M
Propotion
-
Post Valuation
-
Current Round Investors
| Investor Name | Invest Money | Lead Investor | Propotion | |
|---|---|---|---|---|
| Regeneron | - | Yes | - | Detail |
Historical Financing
| Announced Date | Round | Money Raised | Investors | |
|---|---|---|---|---|
| Mar 16, 2022 | Post-IPO Equity | $ 170M | Newtyn Management,Nick Leschly & family | Detail |
